4D Molecular Therapeutics, Inc. (FDMT)
NASDAQ · Manufacturing · Biological products, (no diagnostic substances)
$14.47−$0.2400 (−1.63%) on the dayAs of the close; data may be delayed.
FDMT price, last 12 months
Key stats
- Previous close
- $14.71
- Open
- $14.78
- Day range
- $14.03 – $14.82
- 52-week range
- $6.96 – $16.93
- Volume
- 1M
- Avg volume (20 days)
- 924.6K
- Market cap
- $799.4M
Performance
1W−4.9%
1M−7.0%
3M+24.7%
6M+42.1%
YTD+92.9%
1Y+71.5%
vs S&P 500, 1Y+54.7 pts
Technicals and fundamentals
About 4D Molecular Therapeutics, Inc.
4D Molecular Therapeutics Inc is biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients. Companies focus is on advancing 4D-150 for wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME) through late-stage studies. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-710 and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector).
- Sector
- Manufacturing
- Industry
- Biological products, (no diagnostic substances)
- Listed on
- NASDAQ
- Market cap
- $799.4M